Intercept Pharmaceuticals Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares

[at noodls] – NEW YORK, Oct. 15, 2012 (GLOBE NEWSWIRE) — Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics … more

View todays social media effects on ICPT

View the latest stocks trending across Twitter. Click to view dashboard